CVE-2026-28470
Openclaw command injection
- Published5 Mar 2026
Description
OpenClaw versions prior to 2026.2.2 contain an exec approvals (must be enabled) allowlist bypass vulnerability that allows attackers to execute arbitrary commands by injecting command substitution syntax. Attackers can bypass the allowlist protection by embedding unescaped $() or backticks inside double-quoted strings to execute unauthorized commands.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2026-28470 being actively exploited?
CVE-2026-28470 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.92%.
How severe is CVE-2026-28470?
CVE-2026-28470 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 0.92% probability of exploitation.
Which products are affected by CVE-2026-28470?
Affected products include Openclaw.
How do I fix CVE-2026-28470?
Upgrade affected software to a fixed version, for example Openclaw 2026.2.2 or later, then confirm no affected versions remain in your inventory.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2026-28470 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.